⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5168124 | 0.85 | — | — | |
| SCHEMBL3642757 | 0.84 | — | — | |
| SCHEMBL9671343 | 0.84 | — | — | |
| SCHEMBL9670186 | 0.84 | — | — | |
| SCHEMBL2256664 | 0.77 | — | — | |
| SCHEMBL1748644 | 0.76 | — | — | |
| SCHEMBL571056 | 0.73 | RIPK1 (0.35) | — | |
| SCHEMBL7383796 | 0.73 | — | — | |
| SCHEMBL2256195 | 0.70 | — | — | |
| SCHEMBL4951742 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3210974-B1 | PRODRUG OF ROFLUMILAST | HISAMITSU PHARMACEUTICAL CO (JP) | 2020-01-29 | — | — | EP | disclosed |
| US-9969688-B2 | Roflumilast prodrugs | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2018-05-15 | — | — | US | disclosed |
| EP-3210974-A1 | PRODRUG | Hisamitsu Pharmaceutical Co., Inc. (JP) | 2017-08-30 | — | — | EP | disclosed |
| US-20170233343-A1 | PRODRUG | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2017-08-17 | — | — | US | disclosed |
| US-7919523-B2 | Inhibitors of aspartyl protease | VERTEX PHARMACEUTICALS, INC. (US) | 2011-04-05 | — | — | US | disclosed |
| US-20090042973-A1 | Inhibitors of aspartyl protease | VERTEX PHARMACEUTICALS INCORPORATED | 2009-02-12 | — | — | US | disclosed |
| US-7442718-B2 | Inhibitors of aspartyl protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-10-28 | — | — | US | disclosed |
| EP-1637518-A2 | Inhibitors of aspartyl protease | Vertex Pharmaceuticals Incorporated (US) | 2006-03-22 | — | — | EP | disclosed |
| EP-1159278-B1 | INHIBITORS OF ASPARTYL PROTEASE | VERTEX PHARMA (US) | 2005-11-30 | — | — | EP | disclosed |
| US-6780855-B2 | TREATING A PATIENT SUFFERING FROM AN ESTROGEN DEPENDENT-DISEASE | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-08-24 | — | — | US | disclosed |
| EP-0752999-B1 | 2,4-DIPHOSPHONOGLUTARIC ACID DERIVATIVES, METHODS OF PREPARING SUCH COMPOUNDS AND DRUGS CONTAINING THEM | BOEHRINGER MANNHEIM GMBH (DE) | 1998-10-28 | — | — | EP | disclosed |
| US-5705659-A | Intermediates for the synthesis of 16-phenoxy-prostatrienoic acid derivatives and a preparing method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1998-01-06 | — | — | US | disclosed |
| US-5698541-A | DISEASES OF CALCIUM METABOLISM; OSTEOPOROSIS | BOEHRINGER MANNHEIM GMBH (DE) | 1997-12-16 | — | — | US | disclosed |
| EP-0777666-A1 | NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | MERRELL PHARMACEUTICALS INC. (US) | 1997-06-11 | — | — | EP | disclosed |
| WO-1997019074-A1 | SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL-AMINO)PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1997-05-29 | — | — | WO | disclosed |
| US-5571936-A | Intermediates for the synthesis of 16-phenoxy-prostatrienoic acid derivatives and a preparing method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1996-11-05 | — | — | US | disclosed |
| US-5559258-A | Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-09-24 | — | — | US | disclosed |
| WO-1996006094-A1 | NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | MERRELL PHARMACEUTICALS INC. (US) | 1996-02-29 | — | — | WO | disclosed |
| EP-0548793-A2 | Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-06-30 | — | — | EP | disclosed |
| EP-0134696-A1 | Preparation of 4-substituted-3-pyrazolidinones | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-03-20 | — | — | EP | disclosed |